As Insurers Drop GLP-1 Coverage, Advocates Search for a Hero in Obesity
Insurers are cutting coverage for costly GLP-1 weight loss drugs, sparking backlash from advocates who say they're vital for treating obesity.
Insurers are cutting coverage for costly GLP-1 weight loss drugs, sparking backlash from advocates who say they're vital for treating obesity.
The combined organization would serve nearly 2.4 million members in Massachusetts, Maine, Connecticut, New Hampshire and Rhode Island.
Healthcare decision-makers, especially at pharmaceutical companies, must prioritize patient input. Data collected from social media listening is a significant step in the right direction.